Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Natasha Rolls, Cecilie Yssing, Mette Bøgelund, Jonas Håkan-Bloch & Lasse de Fries Jensen. (2022) Utilities associated with stoma-related complications: peristomal skin complications and leakages. Journal of Medical Economics 25:1, pages 1005-1014.
Read now
Read now
Ariane K. Kawata, William R. Lenderking, Olabimpe R. Eseyin, David Kerstein, Joice Huang, Hui Huang, Pingkuan Zhang & Huamao M. Lin. (2019) Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study. Journal of Medical Economics 22:9, pages 924-935.
Read now
Read now
Marissa Blieden Betts, Shravanthi R. Gandra, Lung-I Cheng, Anna Szatkowski & Peter P. Toth. (2018) Differences in utility elicitation methods in cardiovascular disease: a systematic review. Journal of Medical Economics 21:1, pages 74-84.
Read now
Read now
Katie D Stewart, Joseph A Johnston, Louis S Matza, Sarah E Curtis, Henry A Havel, Stephanie A Sweetana & Heather L Gelhorn. (2016) Preference for pharmaceutical formulation and treatment process attributes. Patient Preference and Adherence 10, pages 1385-1399.
Read now
Read now
Sara Olofsson, Hanna Norrlid & Ulf Persson. (2016) Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden. Journal of Medical Economics 19:10, pages 945-958.
Read now
Read now
Yee Vern Yong & Asrul Akmal Shafie. (2016) Development, feasibility, and validity of a computer-based utility assessment tool for measuring asthma-specific health utilities in Malaysia using the standard gamble method. Journal of Asthma 53:8, pages 835-842.
Read now
Read now
Adrian R Levy, Robert M Perkins, Karissa M Johnston, Sean D Sullivan, Vipan C Sood, Wendy Agnese & Mark A Schnitzler. (2014) An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease. International Journal of Nephrology and Renovascular Disease 7, pages 271-280.
Read now
Read now
S. Lane, A. R. Levy, J. Mukherjee, J. Sambrook & H. Tildesley. (2014) The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes. Current Medical Research and Opinion 30:7, pages 1267-1273.
Read now
Read now
Donald W Smith, Evan W Davies, Erika Wissinger, Rachel Huelin, Louis S Matza & Karen Chung. (2013) A systematic literature review of cardiovascular event utilities. Expert Review of Pharmacoeconomics & Outcomes Research 13:6, pages 767-790.
Read now
Read now
Marc Evans, Henrik Holm Jensen, Mette Bøgelund, Jens Gundgaard, Barrie Chubb & Kamlesh Khunti. (2013) Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey. Journal of Medical Economics 16:11, pages 1357-1365.
Read now
Read now
Alison Stopeck, Michael Rader, David Henry, Mark Danese, Marc Halperin, Ze Cong, Yi Qian, Roger Dansey & Karen Chung. (2012) Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. Journal of Medical Economics 15:4, pages 712-723.
Read now
Read now
Stefan Cano, Anne F Klassen, Amie Scott, Achilleas Thoma, David Feeny & Andrea Pusic. (2010) Health outcome and economic measurement in breast cancer surgery: challenges and opportunities. Expert Review of Pharmacoeconomics & Outcomes Research 10:5, pages 583-594.
Read now
Read now
Louis S. Matza, Nicole Yurgin, Kristina S. Boye, Karen Malley & Jodi M. Shorr. (2007) Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Current Medical Research and Opinion 23:9, pages 2051-2062.
Read now
Read now
Louis S Matza, Maria N Stoeckl, Jodi M Shorr & Joseph A Johnston. (2006) Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. Expert Review of Pharmacoeconomics & Outcomes Research 6:4, pages 379-390.
Read now
Read now
Hung-Yi Chuang, Kun-Yu Chao & Jung-Der Wang. (2005) Estimation of Burden of Lead for Offspring of Female Lead Workers: A Quality-Adjusted Life Year (QALY) Assessment. Journal of Toxicology and Environmental Health, Part A 68:17-18, pages 1485-1496.
Read now
Read now
Articles from other publishers (66)
Krister Bykvist. (2023) Can we compare health states when our standards change?. Philosophical Studies.
Crossref
Crossref
Ana Paula Rodrigues Rocha, Luiz Augusto Brusaca, Ana Jéssica dos Santos Sousa, Ana Beatriz Oliveira & Patricia Driusso. (2023) Should the Preference-Based Index Set of Values Be Country or Disease Specific? An Analysis Using Data From Women With Symptoms of Overactive Bladder. Value in Health Regional Issues 38, pages 1-8.
Crossref
Crossref
Naazish S. Bashir, Thomas D. Walters, Anne M. Griffiths, Anthony Otley, Jeff Critch & Wendy J. Ungar. (2023) A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease. Quality of Life Research 32:9, pages 2527-2539.
Crossref
Crossref
Marisa Santos, Andrea L. Monteiro & Bráulio Santos. (2021) EQ-5D Brazilian population norms. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Shazia S. Abbas, Tazeen Majeed, Natasha Weaver, Balakrishnan R. Nair, Peta M. Forder & Julie E. Byles. (2021) Utility estimations of health states of older Australian women with atrial fibrillation using SF-6D. Quality of Life Research 30:5, pages 1457-1466.
Crossref
Crossref
Naazish S. Bashir, Thomas D. Walters, Anne M. Griffiths & Wendy J. Ungar. (2021) An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease. Children 8:5, pages 343.
Crossref
Crossref
David Forner, Graeme Hoit, Christopher W. Noel, Antoine Eskander, John R. de Almeida, Matthew H. Rigby & David Naimark. (2020) Decision Modeling for Economic Evaluation in Otolaryngology–Head and Neck Surgery: Review of Techniques. Otolaryngology–Head and Neck Surgery 164:4, pages 741-750.
Crossref
Crossref
Shinichi Noto, Takeru Shiroiwa, Makoto Kobayashi, Tatsunori Murata, Shunya Ikeda & Takashi Fukuda. (2020) Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan. Journal of Patient-Reported Outcomes 4:1.
Crossref
Crossref
Barry Dewitt & George W. Torrance. (2020) Incorporating Mortality in Health Utility Measures. Medical Decision Making 40:7, pages 862-872.
Crossref
Crossref
John Yfantopoulos & Athanasios Chantzaras. (2020) Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications. The European Journal of Health Economics 21:5, pages 729-743.
Crossref
Crossref
Louis S. Matza, L. Clark Paramore, Katie D. Stewart, Hayley Karn, Minesh Jobanputra & Andrew C. Dietz. (2019) Health state utilities associated with treatment for transfusion-dependent β-thalassemia. The European Journal of Health Economics 21:3, pages 397-407.
Crossref
Crossref
Brenna M. McElderry, Emily L. Mueller, Abigail Garcia, Aaron E. Carroll & William E. Bennett Jr. (2019) Parents of healthy children assign lower quality of life measure to scenarios labeled as cancer than to identical scenarios not labeled as cancer. BMC Psychology 7:1.
Crossref
Crossref
Alina Khabibullina & Christopher J. Gerry. (2019) Valuing Health States in Russia: A First Feasibility Study. Value in Health Regional Issues 19, pages 75-80.
Crossref
Crossref
Lin Li, J. L. (Hans) Severens & Olena Mandrik. (2019) Disutility associated with cancer screening programs: A systematic review. PLOS ONE 14:7, pages e0220148.
Crossref
Crossref
Hannah L. Bromley, Dennis Petrie, G.Bruce Mann, Carolyn Nickson, Daniel Rea & Tracy E. Roberts. (2019) Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures. Social Science & Medicine 228, pages 142-154.
Crossref
Crossref
Krista L. Best, William C. Miller, François Routhier & Janice J. Eng. (2017) Feasibility of the trial procedures for a randomized controlled trial of a community-based peer-led wheelchair training program for older adults. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Mónica Duarte Oliveira, Andreia Agostinho, Lara Ferreira, Paulo Nicola & Carlos Bana e Costa. (2018) Valuing health states: is the MACBETH approach useful for valuing EQ-5D-3L health states?. Health and Quality of Life Outcomes 16:1.
Crossref
Crossref
Asrul Akmal Shafie, Chin Hui Ng, Subramaniam Thanimalai, Norliza Haron & Anita Bhajan Manocha. (2018) Estimating the utility value of hypoglycaemia according to severity and frequency using the visual analogue scale (VAS) and time trade-off (TTO) survey. Journal of Diabetes & Metabolic Disorders 17:2, pages 269-275.
Crossref
Crossref
K. Steen Carlsson, E. Andersson & E. Berntorp. (2017) Preference-based valuation of treatment attributes in haemophilia A using web survey. Haemophilia 23:6, pages 894-903.
Crossref
Crossref
Joseph P. BroderickOpeolu AdeoyeJordan Elm. (2017) Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke 48:7, pages 2007-2012.
Crossref
Crossref
George E. MacKinnonIIIIIIPatricia van Hanswijck de Jonge & Donald E. Stull. 2017. Understanding Health Outcomes and Pharmacoeconomics. Understanding Health Outcomes and Pharmacoeconomics.
Michael Coppolino, Andrew L. Avins, Andrew Callen & Walton Sumner. (2017) Quantifying Worry in the Face of Uncertainty: Radiation Exposure from Medical Imaging. Journal of Medical Imaging and Radiation Sciences 48:1, pages 16-21.
Crossref
Crossref
Vijay S. Gorantla, Jan A. Plock & Michael R. Davis. 2017. Anesthesia and Perioperative Care for Organ Transplantation. Anesthesia and Perioperative Care for Organ Transplantation
539
552
.
K. Klose, S. Kreimeier, U. Tangermann, I. Aumann & K. Damm. (2016) Patient- and person-reports on healthcare: preferences, outcomes, experiences, and satisfaction – an essay. Health Economics Review 6:1.
Crossref
Crossref
Martin Ridderstråle, Lyndon Marc Evans, Henrik Holm Jensen, Mette Bøgelund, Marie Markert Jensen, Åsa Ericsson & Johan Jendle. (2016) Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Tine Rikke Jørgensen, Charlotte Emborg, Karianne Dahlen, Mette Bøgelund & Andreas Carlborg. (2016) The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries. BMC Psychiatry 16:1.
Crossref
Crossref
Amjad I. Hussain, Andrew M. Garratt, Jan Otto Beitnes, Lars Gullestad & Kjell I. Pettersen. (2015) Validity of standard gamble utilities in patients referred for aortic valve replacement. Quality of Life Research 25:7, pages 1703-1712.
Crossref
Crossref
Amjad I. Hussain, Andrew M. Garratt, Cathrine Brunborg, Svend Aakhus, Lars Gullestad & Kjell I. Pettersen. (2016) Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision‐Making of Aortic Valve Replacement. Journal of the American Heart Association 5:3.
Crossref
Crossref
Ulla Kou Griffiths, Rosa Legood & Catherine Pitt. (2016) Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?. Health Economics 25, pages 29-41.
Crossref
Crossref
Sujin Cho, Hochang Kim, Seon-Ha Kim, Minsu Ock, Yeon-Mok Oh & Min-Woo Jo. (2015) Utility estimation of hypothetical chronic obstructive pulmonary disease health states by the general population and health professionals. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Robert HutchinsAnthony J. VieraStacey L. SheridanMichael P. Pignone. (2015) Quantifying the Utility of Taking Pills for Cardiovascular Prevention. Circulation: Cardiovascular Quality and Outcomes 8:2, pages 155-163.
Crossref
Crossref
Xinke Zhang, Joel W. Hay & Xiaoli Niu. (2014) Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis. CNS Drugs 29:1, pages 71-81.
Crossref
Crossref
Bita Imam, William C Miller, Heather C Finlayson, Janice J Eng, Michael WC Payne, Tal Jarus, Charles H Goldsmith & Ian M Mitchell. (2014) A Telehealth Intervention Using Nintendo Wii Fit Balance Boards and iPads to Improve Walking in Older Adults With Lower Limb Amputation (Wii.n.Walk): Study Protocol for a Randomized Controlled Trial. JMIR Research Protocols 3:4, pages e80.
Crossref
Crossref
Krista L. Best, William C. Miller, Janice J. Eng, François Routhier & Charles Goldsmith. (2014) Randomized controlled trial protocol feasibility: The Wheelchair Self-Efficacy Enhanced for Use (WheelSeeU). Canadian Journal of Occupational Therapy 81:5, pages 308-319.
Crossref
Crossref
George W. Torrance. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Stewart Harris, Muhammad Mamdani, Claus B. Galbo-Jørgensen, Mette Bøgelund, Jens Gundgaard & Danielle Groleau. (2014) The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey. Canadian Journal of Diabetes 38:1, pages 45-52.
Crossref
Crossref
Carlos Delano Mundim Araújo, Daniela Francescato Veiga, Bernardo Hochman, Luiz Eduardo Felipe Abla, Neil Ferreira Novo & Lydia Masako Ferreira. (2014) Health economics and health preference concepts to orthopedics practitioners. Acta Ortopédica Brasileira 22:2, pages 102-105.
Crossref
Crossref
Louis S Matza, Kristina S Boye, David H Feeny, Joseph A Johnston, Lee Bowman & Jessica B Jordan. (2014) Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions. Health and Quality of Life Outcomes 12:1, pages 48.
Crossref
Crossref
Alexis G. Malkin, Judith E. Goldstein, Monica S. Perlmutter & Robert W. Massof. (2013) Responsiveness of the EQ-5D to the Effects of Low Vision Rehabilitation. Optometry and Vision Science 90:8, pages 799-805.
Crossref
Crossref
K. A. McBrien & B. J. Manns. (2013) Haemodiafiltration: not effective or cost-effective compared with haemodialysis. Nephrology Dialysis Transplantation 28:7, pages 1630-1633.
Crossref
Crossref
Edward M Giesbrecht, William C Miller, Janice J Eng, Ian M Mitchell, Roberta L Woodgate & Charles H Goldsmith. (2013) Feasibility of the Enhancing Participation In the Community by improving Wheelchair Skills (EPIC Wheels) program: study protocol for a randomized controlled trial. Trials 14:1, pages 350.
Crossref
Crossref
Marc Evans, Kamlesh Khunti, Muhammad Mamdani, Claus B Galbo-Jørgensen, Jens Gundgaard, Mette Bøgelund & Stewart Harris. (2013) Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health and Quality of Life Outcomes 11:1, pages 90.
Crossref
Crossref
Alexis G. Malkin, Judith E. Goldstein & Robert W. Massof. (2012) Interpretation of Health and Vision Utilities in Low Vision Patients. Optometry and Vision Science 89:3, pages 288-295.
Crossref
Crossref
Daria J. O’Reilly, Feng Xie, Eleanor Pullenayegum, Hertzel C. Gerstein, Janet Greb, Gord K. Blackhouse, Jean-Eric Tarride, Jim Bowen & Ron A. Goeree. (2011) Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Quality of Life Research 20:6, pages 939-943.
Crossref
Crossref
Alessandro Gonçalves Campolina, Adriana Bruscato Bortoluzzo, Marcos Bosi Ferraz & Rozana Mesquita Ciconelli. (2011) Validação da versão brasileira do questionário genérico de qualidade de vida short-form 6 dimensions (SF-6D Brasil). Ciência & Saúde Coletiva 16:7, pages 3103-3110.
Crossref
Crossref
Caroline Koedoot, Clazien Bouwmans, Marie-Christine Franken & Elly Stolk. (2011) Quality of life in adults who stutter. Journal of Communication Disorders 44:4, pages 429-443.
Crossref
Crossref
Kristina S. Boye, Louis S. Matza, Kimberly N. Walter, Kate Van Brunt, Andrew C. Palsgrove & Aodan Tynan. (2010) Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. The European Journal of Health Economics 12:3, pages 219-230.
Crossref
Crossref
Hilary F. Ryder, Christene M. McDonough, Anna N.A. Tosteson & Jon D. Lurie. (2009) Decision Analysis and Cost-Effectiveness Analysis. Seminars in Spine Surgery 21:4, pages 216-222.
Crossref
Crossref
Steven Simoens. (2009) Health Economic Assessment: A Methodological Primer. International Journal of Environmental Research and Public Health 6:12, pages 2950-2966.
Crossref
Crossref
Steven Simoens. 2009. Handbook of Research on Information Technology Management and Clinical Data Administration in Healthcare. Handbook of Research on Information Technology Management and Clinical Data Administration in Healthcare
69
86
.
Kazuhiro Tamayama, Masahide Kondo, Aiko Shono & Ichiro Okubo. (2009) Utility Weights for Allergic Rhinitis Based on a Community Survey with a Time Trade-off Technique in Japan. Allergology International 58:2, pages 201-207.
Crossref
Crossref
N. Muszbek, M.M. Thompson, C.V. Soong, J. Hutton, P. Brasseur & M.R.H.M. van Sambeek. (2008) Systematic Review of Utilities in Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery 36:3, pages 283-289.
Crossref
Crossref
Mark S. Kaplan, Jean-Marie Berthelot, David Feeny, Bentson H. McFarland, Saeeda Khan & Heather Orpana. (2007) The predictive validity of health-related quality of life measures: mortality in a longitudinal population-based study. Quality of Life Research 16:9, pages 1539-1546.
Crossref
Crossref
Samuel Aballéa & Aki Tsuchiya. (2007) Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles. Health Economics 16:5, pages 537-543.
Crossref
Crossref
Nan Luo, Qinan WangDavid Feeny, Geraldine Chen, Shu-Chuen Li & Julian Thumboo. (2016) Measuring Health Preferences for Health Utilities Index Mark 3 Health States: A Study of Feasibility and Preference Differences among Ethnic Groups in Singapore. Medical Decision Making 27:1, pages 61-70.
Crossref
Crossref
Amir Adel Rashidi, Aslam H Anis & Carlo A Marra. (2006) Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Health and Quality of Life Outcomes 4:1.
Crossref
Crossref
Ligia Fu, Danielle Talsma, Fulgencio Baez, Miguel Bonilla, Belgica Moreno, Maria Ah-Chu, Armando Pena, William Furlong & Ronald D. Barr. (2006) Measurement of Health-Related Quality of Life in Survivors of Cancer in Childhood in Central America: Feasibility, Reliability, and Validity. Journal of Pediatric Hematology/Oncology 28:6, pages 331-341.
Crossref
Crossref
Judith Grant, Amy Cranston, John Horsman, William Furlong, Neil Barr, Sheri Findlay & Ronald Barr. (2006) Health status and health-related quality of life in adolescent survivors of cancer in childhood. Journal of Adolescent Health 38:5, pages 504-510.
Crossref
Crossref
Stirling Bryan & Louise Longworth. (2005) Measuring health-related utility:. The European Journal of Health Economics 6:3, pages 253-260.
Crossref
Crossref
Richard Cookson. (2005) QALYs and the capability approach. Health Economics 14:8, pages 817-829.
Crossref
Crossref
George W. Torrance. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
Kristina Secnik, Louis S. Matza, Suzi Cottrell, Eric Edgell, Dominic Tilden & Sally Mannix. (2016) Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom. Medical Decision Making 25:1, pages 56-70.
Crossref
Crossref
David H. Feeny. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
69
92
.
Antje M. Smala, Uwe Siebert, Wolfgang H. Oertel & Richard Dodel. (2004) Reply: Cabergoline versus levodopa therapy. Movement Disorders 19:6, pages 734-736.
Crossref
Crossref
David Feeny, William Furlong, Saroj Saigal & Jian Sun. (2004) Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons. Social Science & Medicine 58:4, pages 799-809.
Crossref
Crossref
John C Sinclair. (2003) Weighing risks and benefits in treating the individual patient. Clinics in Perinatology 30:2, pages 251-268.
Crossref
Crossref